Xsensio Raises Oversubscribed $7 Million Series A to Accelerate Continuous Biosensing Innovation LAUSANNE, Switzerland, March 5 — Swiss deep-tech company Xsensio SA has secured $7 million in an oversubscribed Series A funding round, providing a significant boost to its efforts to bring continuous biochemical monitoring technology into real-world healthcare environments. The investment round was led by San Francisco-based venture capital firm WI Harper, with participation from Privilège …

Xsensio Raises Oversubscribed $7 Million Series A to Accelerate Continuous Biosensing Innovation #Xsensio #SeriesA #Biosensing #HealthcareInnovation #VentureCapital

Xsensio SA Secures $7M in Oversubscribed Series A to Enhance Biosensing Technology Deployment Xsensio SA, a pioneering Swiss deep-tech firm, has successfully raised $7 million in an oversubscribed Series A round to advance its innovative biosensing technologies for real-time health monitoring.

Xsensio SA Secures $7M in Oversubscribed Series A to Enhance Biosensing Technology Deployment #Switzerland #Lausanne #Xsensio #Biosensing #Lab-on-Skin

Xsensio Secures $7M in Oversubscribed Series A Funding for Advanced Biosensing Xsensio SA has successfully closed a $7 million Series A funding round to enhance its wearable biosensing technology, Lab-on-Skin©. This will accelerate its clinical deployment.

Xsensio Secures $7M in Oversubscribed Series A Funding for Advanced Biosensing #Switzerland #Lausanne #Xsensio #Lab-on-Skin #Clinical_Biosensing

Xsensio SA Secures $7 Million in Oversubscribed Series A Funding Xsensio SA has successfully closed a $7 million oversubscribed Series A funding round to enhance its clinical deployment of continuous biosensing technology.

Xsensio SA Secures $7 Million in Oversubscribed Series A Funding #Switzerland #Lausanne #Xsensio #Biosensing #Lab-on-Skin

Xsensio SA Secures $7M in Oversubscribed Series A Funding to Enhance Biosensing Innovations Xsensio SA has successfully closed an oversubscribed Series A financing round, securing $7 million to advance its biosensing technologies, enhancing healthcare monitoring.

Xsensio SA Secures $7M in Oversubscribed Series A Funding to Enhance Biosensing Innovations #Switzerland #HealthTech #Lausanne #Xsensio #Biosensing